|
|
Article: Antiretroviral therapy and health care utilization: a study of privately insured men and women with HIV disease.(Practice Patterns)
- Article from:
- Health Services Research
- Article date:
- August 1, 2004
- Author:
CopyrightCOPYRIGHT 2004 Health Research and Educational Trust. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ensuring access to expensive new drug therapies for persons with HIV disease is important because access to these therapies is related to morbidity and mortality (Palella et al. 1998). Over the past decade, the proportion of costs attributable to drugs has risen from 10 percent to more than 40 percent among persons with HIV disease, and the cost of drug therapy is now between $10,000 and $15,000 per year (Hellinger 1993a; Bozzette et al. 1998, 2001).
The importance of drug therapy is evidenced by the drop in the number of HIV deaths in the United States after the diffusion of drug therapies that include a protease inhibitor or a nonnucleoside reverse ...